August 4, 2020 - Transgene Receives $22.2 million from the Sale of Part of its Minority Stake in Tasly BioPharmaceuticals
(WorldNews China)

Transgene Receives $22.2 million from the Sale of Part of its Minority Stake in Tasly BioPharmaceuticals Strasbourg, France, August 4, 2020, 5:45 p.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that it has raised $22.2 million (€ 19 million) from the sale of 10.3 million shares of its minority stake in Tasly BioPharmaceuticals to a Chinese investment fund. The shares that have been sold represent 38% of Transgene`s total holding in Tasly BioPharmaceuticals. The transaction enhances the Company`s cash position and strengthens its financial visibility until 2022. Following this share...